PathMap Literature Based Discovery Engine
Share your Discovery:
Guaranteed to find unpublished literature based discoveries.
Use of MBTPS1 inhibitors is a plausible strategy to prevent the terminal phase of nuclear death in specific cellular contexts.


Membrane-Bound Transcription Factor Peptidase, Site 1
_gates_from_membrane_bound_transcription_factor_peptidase__site_1
SREBP Activation
_gates_to_srebp_activation
_gates_from_srebp_activation
Cellular Lipid Homeostasis
_gates_to_cellular_lipid_homeostasis
_gates_from_cellular_lipid_homeostasis
Terminal Cell Death
_gates_to_terminal_cell_death
Sarcopenia and Amyotrophic Lateral Sclerosis: Biological Pathways and Analysis


The ALS-T2D comorbidity is driven by a bidirectional, exosome-mediated proteostatic collapse. Peripheral tissues (muscle, pancreas) dictate CNS TDP-43 stability via exosomal miRNAs (miR-126a-5p) and glucose-dependent modifications (O-GlcNAcylation). Conversely, pharmacological activation of ubiquitin-peptidases (e.g., Acarbose targeting USP46) or restitution of glycolytic cofactors (F2,6BP) represent novel, cross-disciplinary therapeutic targets capable of halting systemic proteinopathy.


Diabetes Mellitus, Type 2
_gates_from_diabetes_mellitus__type_2
Extracellular Vesicles
_gates_to_extracellular_vesicles
_gates_from_extracellular_vesicles
DNA-Binding Proteins
_gates_to_dna_binding_proteins
_gates_from_dna_binding_proteins
Amyotrophic Lateral Sclerosis
_gates_to_amyotrophic_lateral_sclerosis













